Sign in
Taking people in United StatesNo phase

How CPAP mask designs affect rebreathing of exhaled air in obstructive sleep apnea

Studies how CPAP mask designs affect rebreathed carbon dioxide in people with obstructive sleep apnea.

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Assessment of Circuit Rebreathing During CPAP Therapy
Status
Recruiting
People taking part
13 people, planned
Started
27 May 2025
Planned end
1 Dec 2025
Type of study
Interventional, 11 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Continuous positive airway pressure (CPAP)
  • Mask exhaust port flow
Record updated
14 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with moderate to severe obstructive sleep apnea who use or have used CPAP. It studies how mask designs affect breathing back exhaled CO₂ during sleep.

Age
21 to 70 years
Sex
All sexes can join.
Disease stage
Moderate to severe obstructive sleep apnea (AHI>20, meaning more than 20 breathing pauses or drops per hour of sleep). BMI 18-40 kg/m2.
Earlier treatment
People must say they use CPAP now or have used it before. Their CPAP pressure must be at most 13 cmH2O, if known.

Main reasons for not taking part

  • Severe mouth-breathing, as reported by the person
  • Needing oxygen at night or other breathing support
  • Severe heart, blood vessel or lung disease
  • Any unstable or sudden medical condition
  • Any other sleep disorder besides OSA, including insomnia

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Moderate to severe OSA (AHI>20)
  • Self-reported CPAP users or have previously used CPAP
  • Self-reported holding pressure of maximum 13 cmH2O (if known)
  • Age: 21-70
  • BMI: 18-40 kg/m2

Who cannot take part

  • Severe cardiovascular or pulmonary disease
  • Any unstable or acute medical condition
  • Any additional sleep disorder, including insomnia, except for OSA
  • Self-reported severe mouth-breathing
  • Requirement for nocturnal supplemental oxygen or other ventilatory support

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 70 years old?

Where in United States

  • Brigham and Women's HospitalBoston, United StatesContact: Atqiya Aishah, PhDTaking people

About the trial

What the trial wants to find out

The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).

The 11 groups in the trial

  • 5 cmH2O with 35L/sTreatment being tested

    35 L/s exhaust flow with 5 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 5 cmH2O with 23L/sTreatment being tested

    23 L/s exhaust flow with 5 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 5 cmH2O with 18L/sTreatment being tested

    18 L/s exhaust flow with 5 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 5 cmH2O with 13L/sTreatment being tested

    13 L/s exhaust flow with 5 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 5 cmH2O with 8L/sTreatment being tested

    8 L/s exhaust flow with 5 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 0 cmH2O with 35L/sPlacebo, for comparison

    35 L/s exhaust flow with 0 cmH₂O PAP

    Treatment: Mask exhaust port flow

  • 10 cmH2O with 35L/sTreatment being tested

    35 L/s exhaust flow with 10 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 10 cmH2O with 23L/sTreatment being tested

    23 L/s exhaust flow with 10 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 10 cmH2O with 18L/sTreatment being tested

    18 L/s exhaust flow with 10 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 10 cmH2O with 13L/sTreatment being tested

    13 L/s exhaust flow with 10 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

  • 10 cmH2O with 8L/sTreatment being tested

    8 L/s exhaust flow with 10 cmH₂O PAP

    Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Circuit Rebreathing During Continuous Positive Airway Pressure (CPAP) Therapy
Plain-language title
How CPAP mask designs affect rebreathing of exhaled air in obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07062770, who can take part
Record updated
14 July 2025